The use of rocuronium and sugammadex for reversing neuromuscular blockade increased dramatically over 6 years in patients with moderate and severe renal impairment. The variation in strategy selection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback